BACKGROUND: The associations between different sources of dietary n-3 (omega-3) and n-6 (omega-6) fatty acids and the risk of depression have not been prospectively studied. OBJECTIVE: The objective was to examine the relation between different n-3 and n-6 types with clinical depression incidence. DESIGN: We prospectively studied 54,632 US women from the Nurses' Health Study who were 50-77 y of age and free from depressive symptoms at baseline. Information on diet was obtained from validated food-frequency questionnaires. Clinical depression was defined as reporting both physician-diagnosed depression and regular antidepressant medication use. RESULTS: During 10 y of follow-up (1996-2006), 2823 incident cases of depression were documented. Intake of long-chain n-3 fatty acids from fish was not associated with depression risk [relative risk (RR) for 0.3-g/d increment: 0.99; 95% CI: 0.88, 1.10], whereas α-linolenic acid (ALA) intake was inversely associated with depression risk (multivariate RR for 0.5-g/d increment: 0.82; 95% CI: 0.71, 0.94). The inverse association between ALA and depression was stronger in women with low linoleic acid (LA) intake (P for interaction = 0.02): a 0.5-g/d increment in ALA was inversely associated with depression in the first, second, and third LA quintiles [RR (95% CI): 0.57 (0.37, 0.87), 0.62 (0.41, 0.93), and 0.68 (0.47, 0.96), respectively] but not in the fourth and fifth quintiles. CONCLUSIONS: The results of this large longitudinal study do not support a protective effect of long-chain n-3 from fish on depression risk. Although these data support the hypothesis that higher ALA and lower LA intakes reduce depression risk, this relation warrants further investigation.
BACKGROUND: The associations between different sources of dietary n-3 (omega-3) and n-6 (omega-6) fatty acids and the risk of depression have not been prospectively studied. OBJECTIVE: The objective was to examine the relation between different n-3 and n-6 types with clinical depression incidence. DESIGN: We prospectively studied 54,632 US women from the Nurses' Health Study who were 50-77 y of age and free from depressive symptoms at baseline. Information on diet was obtained from validated food-frequency questionnaires. Clinical depression was defined as reporting both physician-diagnosed depression and regular antidepressant medication use. RESULTS: During 10 y of follow-up (1996-2006), 2823 incident cases of depression were documented. Intake of long-chain n-3 fatty acids from fish was not associated with depression risk [relative risk (RR) for 0.3-g/d increment: 0.99; 95% CI: 0.88, 1.10], whereas α-linolenic acid (ALA) intake was inversely associated with depression risk (multivariate RR for 0.5-g/d increment: 0.82; 95% CI: 0.71, 0.94). The inverse association between ALA and depression was stronger in women with low linoleic acid (LA) intake (P for interaction = 0.02): a 0.5-g/d increment in ALA was inversely associated with depression in the first, second, and third LA quintiles [RR (95% CI): 0.57 (0.37, 0.87), 0.62 (0.41, 0.93), and 0.68 (0.47, 0.96), respectively] but not in the fourth and fifth quintiles. CONCLUSIONS: The results of this large longitudinal study do not support a protective effect of long-chain n-3 from fish on depression risk. Although these data support the hypothesis that higher ALA and lower LA intakes reduce depression risk, this relation warrants further investigation.
Authors: W C Willett; L Sampson; M L Browne; M J Stampfer; B Rosner; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1988-01 Impact factor: 4.897
Authors: M J Stampfer; W C Willett; F E Speizer; D C Dysert; R Lipnick; B Rosner; C H Hennekens Journal: Am J Epidemiol Date: 1984-05 Impact factor: 4.897
Authors: F B Hu; M J Stampfer; J E Manson; E B Rimm; A Wolk; G A Colditz; C H Hennekens; W C Willett Journal: Am J Clin Nutr Date: 1999-05 Impact factor: 7.045
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Ashwin N Ananthakrishnan; Hamed Khalili; Gauree G Konijeti; Leslie M Higuchi; Punyanganie de Silva; Charles S Fuchs; Walter C Willett; James M Richter; Andrew T Chan Journal: Gut Date: 2013-07-04 Impact factor: 23.059
Authors: Thomas Rutledge; Tanya S Kenkre; Diane V Thompson; Vera A Bittner; Kerry Whittaker; Jo-Ann Eastwood; Wafia Eteiba; Carol E Cornell; David S Krantz; Carl J Pepine; B Delia Johnson; Eileen M Handberg; C Noel Bairey Merz Journal: Am J Med Date: 2014-04-24 Impact factor: 4.965
Authors: William H Coryell; Douglas R Langbehn; Andrew W Norris; Jian-Rong Yao; Lilian N Dindo; Chadi A Calarge Journal: Psychiatry Res Date: 2017-06-21 Impact factor: 3.222
Authors: Claire A Hoffmire; Robert C Block; Kelly Thevenet-Morrison; Edwin van Wijngaarden Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2012-04-01 Impact factor: 4.006
Authors: Michel Lucas; Rania Mekary; An Pan; Fariba Mirzaei; Eilis J O'Reilly; Walter C Willett; Karestan Koenen; Olivia I Okereke; Alberto Ascherio Journal: Am J Epidemiol Date: 2011-10-07 Impact factor: 4.897
Authors: Alexander C Tsai; Michel Lucas; Olivia I Okereke; Eilis J O'Reilly; Fariba Mirzaei; Ichiro Kawachi; Alberto Ascherio; Walter C Willett Journal: Am J Epidemiol Date: 2014-05-08 Impact factor: 4.897
Authors: Michel Lucas; Patricia Chocano-Bedoya; Matthias B Schulze; Mathias B Shulze; Fariba Mirzaei; Éilis J O'Reilly; Olivia I Okereke; Frank B Hu; Walter C Willett; Alberto Ascherio Journal: Brain Behav Immun Date: 2013-10-01 Impact factor: 7.217